Cite
HARVARD Citation
Booth, S. et al. (2022). Key findings from the UKCCMP cohort of 877 patients with haematological malignancy and COVID‐19: disease control as an important factor relative to recent chemotherapy or anti‐CD20 therapy. British journal of haematology. pp. 892-901. [Online].